Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Javier Dorantes Aguilar"'
Autor:
Layla Bouzoubaa, Raymond Balise, Felicia Marie Knaul, Eduardo Undurraga, Michael Touchton, Héctor Arreola-Ornelas, Thalia Porteny, Mariano Sánchez, Oscar Méndez, Marco Faganello, Vaugh Edelson, Benjamin Gygi, Calla Hummel, Silvia Otero, Jorge Insua, Julio Antonio Rosado, Salvador Acevedo Gómez, Miguel Betancourt Cravioto, Karen Jane Burke, Alberto Cairo, Daniel Alberto Díaz Martínez, Javier Dorantes Aguilar, L Lizette González Gómez, Kim Grinfeder, Héctor Hernández Llamas, Sallie Hughes, L Luján López, Lenny Martínez, Víctor Arturo Matamoros Gómez, Cesar Arturo Méndez Lizárraga, Gerardo Pérez Castillo
Publikováno v:
BMJ Global Health, Vol 6, Iss 6 (2021)
Introduction To present an analysis of the Brazilian health system and subnational (state) variation in response to the COVID-19 pandemic, based on 10 non-pharmaceutical interventions (NPIs).Materials and methods We collected daily information on imp
Externí odkaz:
https://doaj.org/article/74c90853a6ef4d3e950d5d706751d784
Autor:
Iris Contreras Hernández, Joaquín F Mould Quevedo, Javier Dorantes Aguilar, Lourdes García, Héctor Arreola Ornelas, Alfonso Rosado Buzzo
Publikováno v:
Reumatología Clínica (English Edition). 8:120-127
Objective To identify, from the Mexican Public Health System perspective, which would be the most cost-effective treatment for patients with fibromyalgia (FM). Material and methods A Markov model including three health states, divided by pain intensi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ded779ee6eefbf27d65e4f62c10ad721
https://doi.org/10.1016/j.reumae.2011.12.003
https://doi.org/10.1016/j.reumae.2011.12.003
Autor:
Emilio Muciño-Ortega, Héctor Arreola-Ornelas, Lourdes García-Mollinedo, Javier Dorantes-Aguilar, Joaquin Mould-Quevedo, Alfonso Rosado-Buzzo
Publikováno v:
PharmacoEconomics Spanish Research Articles. 7:118-132
Objetivo: Las guias clinicas recomiendan tromboprofilaxis en pacientes con riesgo de desarrollar enfermedad tromboembolica venosa (ETV). El objetivo del estudio fue estimar el coste-efectividad de agentes farmacologicos para prevenir/ tratar ETV en p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f679d2e73ed0092c13156871a55d7233
https://doi.org/10.1007/bf03321481
https://doi.org/10.1007/bf03321481
Autor:
Héctor, Arreola-Ornelas, Alfonso, Rosado-Buzzo, Lourdes, García-Mollinedo, Javier, Dorantes Aguilar, Emilio, Muciño-Ortega, Joaquín Federico, Mould-Quevedo
Publikováno v:
Cirugia y cirujanos. 80(5)
Knee surgery is a risk factor for thromboembolic disease. Prophylaxis reduces the risk of this condition.Economic and health consequences of drugs preventing and treating thromboembolic disease in patients undergoing knee surgery from the institution
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ab4a220f3110840b73bb41a5754b8a3
https://pubmed.ncbi.nlm.nih.gov/23351443
https://pubmed.ncbi.nlm.nih.gov/23351443
Análisis de coste-efectividad en el tratamiento farmacológico del síndrome de fibromialgia en México
Autor:
Javier Dorantes Aguilar, Joaquín F Mould Quevedo, Iris Contreras Hernández, Alfonso Rosado Buzzo, Héctor Arreola Ornelas, Lourdes García
Publikováno v:
Reumatología Clínica.
Resumen Objetivo Identificar desde la perspectiva del proveedor de servicios de salud publica en Mexico el tratamiento mas coste-efectivo para pacientes con sindrome de fibromialgia (SFM). Material y metodos Mediante un modelo de Markov con 3 estados
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4840aa0cd705bc46ff1215e6033b0a9e
https://doi.org/10.1016/j.reuma.2011.12.009
https://doi.org/10.1016/j.reuma.2011.12.009